Literature DB >> 10994746

Drug treatment of hypertension: the reduction of pulse pressure does not necessarily parallel that of systolic and diastolic blood pressure.

M E Safar, A Rudnichi, R Asmar.   

Abstract

Drug treatment of hypertension reduces systolic and diastolic blood pressure according to a well-established dose-response curve. Whether there is a parallel decrease in mean blood pressure and pulse pressure has not been investigated in the past Recent analysis of the literature and personal work indicates that, during drug treatment of hypertension, a significant decrease in systolic and diastolic blood pressure may be associated with an unchanged pulse pressure, a situation that might contribute to maintaining cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994746     DOI: 10.1097/00004872-200018090-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Pulse pressure: an important tool in cardiovascular pharmacology and therapeutics.

Authors:  Roland Asmar; Michel Safar; Patrice Queneau
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Hypertension in the elderly.

Authors:  M Pestana
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease.

Authors:  Susan J Zieman; David A Kass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Sex-specific effects of ACE I/D and AGT-M235T on pulse pressure: the HyperGEN Study.

Authors:  Amy I Lynch; Donna K Arnett; James S Pankow; Michael B Miller; Kari E North; John H Eckfeldt; Steven C Hunt; Dabeeru C Rao; Luc Djoussé
Journal:  Hum Genet       Date:  2007-05-10       Impact factor: 4.132

Review 5.  Wide pulse pressure: A clinical review.

Authors:  Kevin S Tang; Edward D Medeiros; Ankur D Shah
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-28       Impact factor: 3.738

6.  Age-specific impact of self-monitored pulse pressure on hypertensive target organ damage in treated hypertensive patients.

Authors:  Kazuo Eguchi; Yoshio Matsui; Seiichi Shibasaki; Joji Ishikawa; Satoshi Hoshide; Shizukiyo Ishikawa; Tomoyuki Kabutoya; Joseph E Schwartz; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-07       Impact factor: 3.738

7.  Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database.

Authors:  Joel Neutel; David H G Smith
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.